A British court rejected Kellogg's arguments in its legal action against the UK government over new regulations preventing it from prominently displaying some of its breakfast cereals in supermarkets due to their sugar content.
Kellogg argued that the UK government's way of measuring the nutritional value of cereal without milk or yogurt is “wrong”.
The new regulations, which come into effect in October, are designed to help tackle childhood obesity and will restrict the promotion of food and drink products that are high in fat, salt, or sugar.
Kellogg noted that it supported the government’s work to tackle obesity, demonstrated by its past efforts to reduce sugar and salt in its cereals.
A Kellogg spokesperson said that while they respect the court's decision and do not intend to appeal, they still believe that cereals should be measured with milk as it is the way most people eat them.
They also raised their concern that the government introduced these regulations without proper parliamentary scrutiny.


Federal Reserve Faces Subpoena Delay Amid Investigation Into Chair Jerome Powell
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Washington Post Publisher Will Lewis Steps Down After Layoffs
Supreme Court Signals Skepticism Toward Hawaii Handgun Carry Law
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



